Open Water Rx review

Open Water Rx for moms: our verdict

Clear, all-inclusive standing prices — $249 semaglutide, $339 tirzepatide, $279 the oral tablet — after we re-checked today the price contradiction that used to exist between pages on the site and confirmed which number is real. The advertised starting price is $159, but the regular rate settles nearer $249/mo — so read the headline as an intro offer, not as the monthly cost.

We looked at Open Water Rx the way moms actually have to: not just the monthly cost, but the right timing around pregnancy and nursing and honest, clear pricing from the start — the parts a generic weight-loss review skips.

What Open Water Rx actually costs

• Compounded semaglutide — Weekly injection: $159 to start, then $249/mo
• Compounded tirzepatide — Weekly injection: $219 to start, then $339/mo
• Oral semaglutide — Daily tablet (no injections): $279/mo

For context, the typical ongoing price on our list is around $179/mo, so Open Water Rx sits at the pricier end.

Open Water Rx prices flat across doses, so it doesn't climb as your dose does — which matters, because most women spend months titrating up.

That price covers the consult, the medication and shipping.

The medications Open Water Rx prescribes

Open Water Rx lists semaglutide and tirzepatide. Offering both gives a prescribing clinician options, but PCOS or a history of gestational diabetes alone does not establish which medication is right for you. Compounded GLP-1s are not FDA-approved finished products. Confirm the exact formulation and dispensing pharmacy; an approved brand’s trial results do not establish the quality or equivalence of a compounded product.

If you prefer an option without needles, check the exact product offered. FDA-approved oral semaglutide tablets have their own clinical trials and prescribing labels. Compounded oral or sublingual products are different: they are not FDA-approved and cannot be assumed equivalent to an approved tablet or injection. Ask the clinician about the formulation, evidence and instructions.

Where it operates. Open Water Rx lists its coverage as: All 50 states (as advertised).

Where Open Water Rx fits — and where it doesn't — for moms

A good fit if…

• you want to discuss the right timing around pregnancy and nursing with the prescribing clinician; confirm who provides your care and how questions are handled.
• you want to discuss both semaglutide and tirzepatide with your prescribing clinician.
• broad access matters to you; confirm treatment eligibility in your current state and any new state before moving.

Look elsewhere if…

• you specifically want an FDA-approved brand-name pen with its own pregnancy and breastfeeding label.

Trust, safety and oversight

Before choosing Open Water Rx, confirm the dispensing pharmacy and the clinician responsible for your prescription. Public information alone does not establish the quality of care you will receive. As with any compounded GLP-1, the most useful thing moms can do is confirm which licensed pharmacy fills the prescription and what's in the formula — we explain how we score oversight in our scoring methodology.

Pregnancy and breastfeeding need separate discussions with your clinician. GLP-1 weight-loss treatment is not recommended during pregnancy. During breastfeeding, the exact drug and formulation matter: Wegovy tablets are not recommended because of the SNAC absorption ingredient. Injectable semaglutide and tirzepatide labels call for weighing benefits, risks and the limits of infant-safety data; they do not establish that treatment is safe for every nursing parent. Compounded products do not inherit FDA approval from the branded drug. Discuss your own medication and timing before starting or changing treatment.

The bottom line

Open Water Rx is a reasonable option — weigh it on the right timing around pregnancy and nursing and honest, clear pricing from the start against the alternatives below. For moms comparing another compounded offer, CoreAge Rx describes prices and terms to confirm for the selected dose and plan.